A Study of TAK-079 in People With Generalized Myasthenia Gravis

NCT04159805 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda